Compliance with drug therapy in rheumatoid arthritis. A longitudinal European study

Joint Bone Spine

Volumn 67, Issue 3, 2000, Pages 178-182

  Viller, Frédérique ^a   Guillemin, Francis ^b   Briançon, Serge ^b   Mourn, Torbjflrn ^c   Suurmeijer, Theo ^c   Van Heuvel, Wim Den ^b  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Compliance; Drug therapy; Longitudinal study; Rheumatoid arthritis

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; AGED; ARTHRITIS; ARTICLE; DISEASE DURATION; FEMALE; HUMAN; ILLNESS BEHAVIOR; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; EUROPE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 0034039570     PISSN: 11698446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Blanchard F, Briançon S, Guillemin F, van den Heuvel W, Manciaux M, Sandermann R, et al. European research on incapacitating diseases and social support. Int J Health Sci 1990 : 1 : 217-28.
2. Arnett FC Hdworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. the American Rheumatism Association 1987 revised criteria for the classification ol rheumatoid arthritis. Arthritis Rheum 1988 ; 31 : 315-24.
3. Fries JF, Spitz P, Kraincs RG, Holinan HR. Measurement ol patient outcome in arthritis. Arthritis Rheum 1980 ; 23 : 137-45.
4. Viller F, Guillemin F, Briançon S, Mourn I, Suunneijer T. van den Heuvel W. Compliance to drug treatment of rheumatoid arthritis patients: a three-year longitudinal study-. J Rheumatol 1999 ; 26 : 2114-22.
5. Fee P. Tan LJP. Drug compliance in outpatients with rheumatoid arthritis. Aust N Z J Med 1979 : 9 : 274-7.
6. Belcon MC, Haynes RB, Tugwell P. A critical review of compliance studies in rheumatoid arthritis. Arthritis Rheum 1984 : 27 : 1227-33.
7. Deyo RA, Inui TS, Sullivan B. Noncompliance with arthritis drugs: magnitude, correlates, and clinical implications. JJ Rheumatol 1981 ; 8 : 931-6.
8. Siephenson Bj, Rowe BH, Haynes RB, Macharia WM, Leon C. Is this patient taking the treatment as prescribed? JAMA 1993 ; 269 : 27-49-81.
9. Cramer AJ, Mattson RH, Prevey ML, Scheycr RD, Ouellette VI . Flow often is medication taken as prescribed? JAMA 1989 ; 261 : 3273-7.
10. Tarlov AR, Ware JF, Sheldon Greenfield JP, Nelson FC, Perrin E, Zubkoff M. The medical outcomes study. An application of methods for monitoring the results of medical care. (AMA 1989 ; 262 : 925-30.
11. Buchbinder R, Bombardier C, Yeung M, Tugwell P. Which outcome measures should be used in rheumatoid arthritis clinical trials? Arthritis Rheum 1995 ; 38 : 1568-80.
12. Bradley LA. Adherence with treatment regimens among adult rheumatoid arthritis patients: current status and future directions. Arthritis Care Res 1989 : 2 : 33-9.
13. Dunbar J, Dunning EJ, Dwyer K. Compliance measurement with arthritis regimen. Arthritis Care Res 1989 : 2 : 8-16.
14. Elliot WJ. Compliance strategies. Curr Opin Nephrol Hypertens 1994 ; 3 : 27 1-8.
15. Craig HM. Accuracy of indirect measures of medication compliance in hypertension. Res Nurs Health 1985 ; 8 : 61-6.
16. Richardson JL. Perspectives on compliance with drug regimens among the elderly. J Compliance Health Care 1986 ; 1 : 33-45.
17. 7 Haynes RB, Wayne Taylor D, Sackett DF, Gibson FS, Bernholz CD. Murkherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension 1980 ; 2 : 757-64.